Becton, Dickinson and Company
์๊ฐ์ด์ก
$49.6B
๊ธ๋ก๋ฒ ์์
#263
์ญ๋ ์ต๊ณ ์น
$51.5B
2019-12-31
์ด ์ฑ์ฅ๋ฅ
+0%
2026๋ ์ดํ
Market Cap Context
- Larger than 28% of the 367 companies we track (globally).
- Equivalent to 0.2% of United States's GDP (2025 data).
- Just above: #262 United Overseas Bank Limited ($50.2B)
- Just below: #264 BASF SE ($48.2B)
- Best year: 1998 (+72%). Worst year: 1999 (-36%).
Becton, Dickinson and Company Financial Breakdown (FY 2025)
Source: Yahoo Finance โ BDX annual filings (2025) โ$21.8B revenue ยท $3.0B operating income ยท $1.7B net income
- โOperating margin: 13.7% on $21.8B in revenue.
- โR&D is 5.8% of revenue ($1.3B).
- โNet income margin: 7.7% โ $1.7B in profit.
- โFree cash flow: $2.7B (12.2% of revenue).
Cost / Operating Expenses
Total operating expenses $18.9B
Total
$18.5B
Capital Expenditures
$0.8B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$2.7B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Becton, Dickinson and Company ์๊ฐ
Becton, Dickinson and Company is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain areas.
Becton, Dickinson and Company ์๊ฐ์ด์ก ์ถ์ด (2026โ2026)
Becton, Dickinson and Company vs Sector Peers by Market Cap
Becton, Dickinson and Company ๋น๊ต
์์ ์ถ์ด
| ์ฐ๋ | ์๊ฐ์ด์ก | ์์ | ์ ๋ ๋๋น ๋ณํ |
|---|---|---|---|
| 2026 | $49.6B | #263(โ10) | +20.2% |
| 2025 | $41.3B | #273(โ29) | -12.7% |
| 2024 | $47.2B | #244(โ21) | -5.4% |
| 2023 | $50.0B | #223(โ48) | -2.7% |
| 2022 | $51.3B | #175(โ34) | +5.1% |
| 2021 | $48.9B | #209(โ29) | +1.9% |
| 2020 | $48.0B | #180(โ43) | -6.8% |
| 2019 | $51.5B | #137(โ10) | +22.2% |
| 2018 | $42.1B | #127(โ16) | +6.6% |
| 2017 | $39.5B | #143(โ8) | +31.4% |
| 2016 | $30.1B | #151(โ5) | +9.2% |
| 2015 | $27.5B | #146(โ13) | +12.6% |
| 2014 | $24.4B | #159(โ14) | +28.4% |
| 2013 | $19.0B | #173(โ8) | +44.5% |
| 2012 | $13.2B | #181(โ15) | +7.2% |
| 2011 | $12.3B | #166(โ12) | -9.8% |
| 2010 | $13.6B | #154(โ1) | +9.4% |
| 2009 | $12.5B | #153(โ26) | +17.7% |
| 2008 | $10.6B | #127(โ30) | -17.1% |
| 2007 | $12.8B | #157(โ6) | +20.7% |
| 2006 | $10.6B | #163(โ4) | +18.4% |
| 2005 | $8.9B | #159(โ12) | +7.1% |
| 2004 | $8.3B | #147(โ13) | +39.9% |
| 2003 | $6.0B | #160(โ4) | +35.6% |
| 2002 | $4.4B | #156(โ8) | -6.3% |
| 2001 | $4.7B | #164(โ15) | -3.2% |
| 2000 | $4.9B | #149(โ19) | +30.2% |
| 1999 | $3.7B | #130(โ42) | -36.3% |
| 1998 | $5.8B | #88(โ25) | +72.3% |
| 1997 | $3.4B | #113(โ9) | +16.7% |
| 1996 | $2.9B | #104(โ10) | +17.0% |
| 1995 | $2.5B | #94(โ4) | +58.6% |
| 1994 | $1.6B | #90 |
๊ธฐํ ํฌ์ค์ผ์ด ๊ธฐ์
์์ฃผ ๋ฌป๋ ์ง๋ฌธ
What is Becton, Dickinson and Company's market cap?
Becton, Dickinson and Company (BDX) has a market capitalization of $49.6B, making it the #263 largest company in the world by market cap.
What was Becton, Dickinson and Company's highest market cap?
Becton, Dickinson and Company's all-time high market cap was $51.5B, reached in 2019-12-31. Its highest rank was #137 in 2019.
What sector is Becton, Dickinson and Company in?
Becton, Dickinson and Company is in the Healthcare sector, specifically the Medical Instruments & Supplies industry. It is based in United States.
How has Becton, Dickinson and Company's market cap changed over time?
Becton, Dickinson and Company has been tracked since 2026. Its market cap has grown by 0% from $49.6B in 2026 to $49.6B today.